Aug 06, 2021 / 05:30AM GMT
Nitin Agarwal - DAM Capital Advisors Limited, Research Division - Head of Research
Hi. Good morning, everyone, and a very warm welcome to Ipca Labs Q1 FY '22 Earnings Call, hosted by DAM Capital Advisors Private Limited. On the call today, we have representing Ipca Lab management, Mr. A.K. Jain, Joint Managing Director; and Mr. Harish Kamath, Corporate Counsel and Company Secretary.
I will hand over the call to Mr. Jain to make some opening comments, and then we will open the floor for Q&A. Please go ahead, sir.
Ajit Kumar Bhanwarlal Jain - Ipca Laboratories Limited - CFO, Joint MD & Executive Director
Good morning to all participants. Thanks for taking out time and joining us on Q1 FY '22 earning call. Today's earning call and discussions and answer given may include forward-looking statement based on our current business expectations that must be viewed in conjunction with risks that pharmaceutical business faces. Our actual future financial performance may differ from what is projected or perceived. You may use your own judgment on the
Q1 2022 IPCA Laboratories Ltd Earnings Call Hosted by Dam Capital Advisors Ltd Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot